Europe — EMA

Ondansetron Kalceks

Ondondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adult and pediatric patients.

GNH USA supplies Ondansetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Ondansetron used for?

Ondansetron Kalceks is a selective 5‑HT3 receptor antagonist that acts on the serotonergic pathway of vomiting. It ind : - Chemotherapy‑ : ... .... .... .... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →